KUALA LUMPUR, May 25 (Xinhua) — Malaysia’s efforts in researching and producing human vaccines has been given a boost on Wednesday with the signing of a memorandum of understanding (MOU) between Chinese company CanSino Biologics and two Malaysian partners.
The tripartite MOU will see CanSino formalize its relationship with Malaysian pharmaceutical company Solution Biologics and the National Institutes of Biotec